<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34352873</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2444-054X</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>4</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Cirugia y cirujanos</Title><ISOAbbreviation>Cir Cir</ISOAbbreviation></Journal><ArticleTitle>Coriocarcinoma de placenta metast&#xe1;sico en embarazo de 34 semanas. Revisi&#xf3;n y manejo.</ArticleTitle><Pagination><StartPage>534</StartPage><EndPage>537</EndPage><MedlinePgn>534-537</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/CIRU.19001402</ELocationID><Abstract><AbstractText>El coriocarcinoma es un tumor de la placenta agresivo y poco frecuente que forma parte de las denominadas enfermedades trofobl&#xe1;sticas gestacionales. Presentamos el caso de una mujer de 22 a&#xf1;os nul&#xed;para que, en el transcurso del embarazo, en la semana 34, presenta metrorragia con hemoptisis de forma espont&#xe1;nea. Se realiza una tomograf&#xed;a computarizada en la que se aprecian n&#xf3;dulos compatibles con met&#xe1;stasis, catalog&#xe1;ndose como posible coriocarcinoma metast&#xe1;sico. Se programa para ces&#xe1;rea preferente y se inicia tratamiento quimioter&#xe1;pico. Este tumor es muy sensible a la quimioterapia y presenta un alto &#xed;ndice de supervivencia, aunque en los casos metast&#xe1;sicos puede ser mortal. Choriocarcinoma is a rare, aggressive placental tumor that is part of so-called gestational trophoblastic diseases. We present the case of a 22-year-old nulliparous woman who spontaneously presents metrorrhagia with hemoptysis in the course of pregnancy at the 34<sup>th</sup> week. A tomography scan is performed to confirm nodules compatible with metastasis, cataloguing it as a possible metastatic choriocarcinoma. A cesarean section is preferably scheduled and treatment with chemotherapy is initiated. Choriocarcinoma is a tumor very sensitive to chemotherapy and has a high survival rate, although in metastatic cases the disease is usually fatal.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2021 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moreno-Gomez</LastName><ForeName>Blanca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castillo-Aznar</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tejedor-Vargas</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Domingo</LastName><ForeName>Juan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millaruelo-Rami</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Morente</LastName><ForeName>Marimar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xf3;n-Navarro</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Metastatic placenta choriocarcinoma in a 34 week pregnancy. Revision and management.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Cir Cir</MedlineTA><NlmUniqueID>0372736</NlmUniqueID><ISSNLinking>0009-7411</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="Y">Placenta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Choriocarcinoma</Keyword><Keyword MajorTopicYN="N">Coriocarcinoma</Keyword><Keyword MajorTopicYN="N">Coriocarcinoma metast&#xe1;sico</Keyword><Keyword MajorTopicYN="N">Embarazo</Keyword><Keyword MajorTopicYN="N">Metastatic choriocarcinoma</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>20</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34352873</ArticleId><ArticleId IdType="doi">10.24875/CIRU.19001402</ArticleId><ArticleId IdType="pii">j89/4/534</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33783460</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1665-1146</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>Boletin medico del Hospital Infantil de Mexico</Title><ISOAbbreviation>Bol Med Hosp Infant Mex</ISOAbbreviation></Journal><ArticleTitle>[Preterm neonate with spontaneous intestinal perforation of very early presentation].</ArticleTitle><Pagination><StartPage>143</StartPage><EndPage>147</EndPage><MedlinePgn>143-147</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/BMHIM.20000054</ELocationID><Abstract><AbstractText>Introducci&#xf3;n: La perforaci&#xf3;n intestinal espont&#xe1;nea es una condici&#xf3;n que afecta principalmente a neonatos pret&#xe9;rmino. Caso cl&#xed;nico: Se presenta el caso de un neonato pret&#xe9;rmino de 26 semanas de gestaci&#xf3;n con neumoperitoneo en las primeras 24 horas de vida. Por lo precoz del cuadro y los hallazgos radiol&#xf3;gicos, la primera hip&#xf3;tesis diagn&#xf3;stica fue una perforaci&#xf3;n g&#xe1;strica. Sin embargo, en la laparotom&#xed;a se encontr&#xf3; una perforaci&#xf3;n ileal &#xfa;nica, sin hallazgos de enterocolitis. Conclusiones: La perforaci&#xf3;n intestinal espont&#xe1;nea se ha asociado con intervenciones m&#xe9;dicas, como el uso concomitante de esteroides e indometacina. Otras intervenciones, como el uso de magnesio prenatal y la colocaci&#xf3;n de surfactante pulmonar de forma m&#xed;nimamente invasiva, se han propuesto como factores de riesgo para su desarrollo. En la actualidad, deben evaluarse la perforaci&#xf3;n intestinal espont&#xe1;nea y sus asociaciones. Las presentes y futuras investigaciones podr&#xed;an contribuir a aclarar el papel de las intervenciones mencionadas en la revisi&#xf3;n preliminar de la literatura.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alvarado-Socarras</LastName><ForeName>Jorge L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Unidad Neonatal, Fundaci&#xf3;n Cardiovascular de Colombia, Hospital Internacional de Colombia, Bucaramanga, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Capacho</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad Neonatal, Fundaci&#xf3;n Cardiovascular de Colombia, Hospital Internacional de Colombia, Bucaramanga, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni&#xf1;o-Tovar</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Unidad Neonatal, Fundaci&#xf3;n Cardiovascular de Colombia, Hospital Internacional de Colombia, Bucaramanga, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinilla-Orejana</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departamento de Cirug&#xed;a Pedi&#xe1;trica, Fundaci&#xf3;n Cardiovascular de Colombia. Bucaramanga, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Prematuro con perforaci&#xf3;n intestinal espont&#xe1;nea de presentaci&#xf3;n muy precoz.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Bol Med Hosp Infant Mex</MedlineTA><NlmUniqueID>0414106</NlmUniqueID><ISSNLinking>0539-6115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007416" MajorTopicYN="Y">Intestinal Perforation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Perforaci&#xf3;n intestinal espont&#xe1;nea</Keyword><Keyword MajorTopicYN="N">Sulfato de magnesio</Keyword><Keyword MajorTopicYN="N">Enterocolitis necrosante</Keyword><Keyword MajorTopicYN="N">Prematuro</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33783460</ArticleId><ArticleId IdType="doi">10.24875/BMHIM.20000054</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33227809</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>23</Day></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>[Spontaneous coronary dissection associated with systemic lupus erythematosus].</ArticleTitle><Pagination><StartPage>114</StartPage><EndPage>120</EndPage><MedlinePgn>114-120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.20000020</ELocationID><Abstract><AbstractText>Se presenta el caso de una paciente de 29 a&#xf1;os con antecedente de lupus eritematoso sist&#xe9;mico diagnosticado 15 a&#xf1;os antes, que desarroll&#xf3; nefropat&#xed;a l&#xfa;pica actualmente en di&#xe1;lisis peritoneal, cuadro de miopericarditis en 2012 y bajo tratamiento inmunosupresor. Inici&#xf3; con deterioro de su clase funcional por disnea y angina 2 semanas previas al ingreso. Se le realiz&#xf3; ecocardiograma, el cual report&#xf3; insuficiencias mitral y tricusp&#xed;dea graves. Posteriormente present&#xf3; angina en reposo asociada a descarga adren&#xe9;rgica y vagal. A su ingreso se descarta actividad l&#xfa;pica por reumatolog&#xed;a. Por presentaci&#xf3;n cl&#xed;nica, cambios en electrocardiograma y biomarcadores, se realiz&#xf3; cateterismo cardiaco, que report&#xf3; enfermedad coronaria trivascular con ectasia coronaria Markis I y disecci&#xf3;n coronaria de ramo intermedio y circunfleja posterior a la primera marginal obtusa. Se consider&#xf3; por el servicio de cirug&#xed;a cardiotor&#xe1;cica realizar intervenci&#xf3;n con puente coronario posterior a disecci&#xf3;n del ramo intermedio, marginal obtusa y posterolateral, as&#xed; como cambio valvular mitral y plastia tricusp&#xed;dea. La disecci&#xf3;n coronaria espont&#xe1;nea es m&#xe1;s frecuente en las mujeres (70%); puede presentarse como angina inestable y hasta como muerte s&#xfa;bita. La asociaci&#xf3;n con lupus eritematoso sist&#xe9;mico es poco frecuente, con una incidencia del 0.42%. En la nefropat&#xed;a l&#xfa;pica es una manifestaci&#xf3;n poco frecuente de vasculitis extrarrenal. El tratamiento de elecci&#xf3;n depende del n&#xfa;mero de vasos afectados y del estado hemodin&#xe1;mico, por lo que es necesario individualizarlo para cada paciente.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-S&#xe1;nchez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a Cl&#xed;nica, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a Intervencionista, Unidad de Hemodin&#xe1;mica Cardiovascular, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero</LastName><ForeName>Yuyi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a y Ecocardiograf&#xed;a, Unidad de Cuidados Intensivos Coronarios. Centro M&#xe9;dico Nacional La Raza Dr. Antonio Fraga Mouret, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seniscal</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Centro M&#xe9;dico ABC, UNAM. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Disecci&#xf3;n coronaria espont&#xe1;nea asociada a lupus eritematoso sist&#xe9;mico.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C565153">Coronary Artery Dissection, Spontaneous</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003330" MajorTopicYN="N">Coronary Vessel Anomalies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="N">Vascular Diseases</DescriptorName><QualifierName UI="Q000151" MajorTopicYN="Y">congenital</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>A 29 year old female with a past medical history of systemic lupus erythematosus, diagnosed 15 years earlier, presents with lupus nephritis, currently on peritoneal dialysis. She had myopericarditis in 2012 and is currently on immunosuppressants. The patient began with exertional dyspnea and angina 2 weeks before admission. An echocardiogram was performed, reporting severe mitral and tricuspid insufficiency. Afterwards, the patient presented with resting angina associated with an adrenergic and vagal response. Initially, rheumatology ruled out autoimmune activity caused by lupus. We performed a coronary angiogram based on clinical presentation, EKG changes and biomarkers, finding a trivascular coronary artery disease classified as a Markis I coronary artery ectasia and a coronary dissection of the ramus intermedius and the circumflex, posterior to the first obtuse marginal artery. Cardiothoracic surgery considered intervention with a coronary bridge posterior to the dissection of the intermedius ramus artery, marginal obtuse and posterolateral artery, as well as a mitral valve replacement and a tricuspid valve repair. Coronary dissection is more common in women (70%), clinical presentation varies from unstable angina to sudden death. In lupus nephritis, it is an uncommon form of extra renal vasculitis. Treatment depends on the number of arteries affected, as well as the haemodynamic state of the patient. It is imperative to individualize treatment options.</AbstractText></OtherAbstract><CoiStatement>Ninguno.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>23</Day><Hour>20</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33227809</ArticleId><ArticleId IdType="pmc">PMC8258900</ArticleId><ArticleId IdType="doi">10.24875/ACM.20000020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mortensen KH, Thuesen L, Kristensen IB, Christiansen EH. Spontaneous coronary artery dissection:a Western Denmark Heart Registry study. Catheter Cardiovasc Interv. 2009;74:710&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19496145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hering D, Piper C, Hohmann C, Schultheiss HP, Horstkotte D. [Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection.] Z Kardiol. 1998;87:961&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">10025069</ArticleId></ArticleIdList></Reference><Reference><Citation>Saw J, Mancini GBJ, Humphries KH. Contemporary review on spontaneous coronary artery dissection. J Am Coll Cardiol. 2016;68:297&#x2013;312. [Published correction appears in J Am Coll Cardiol. 2016;68:1606.]</Citation><ArticleIdList><ArticleId IdType="pubmed">27417009</ArticleId></ArticleIdList></Reference><Reference><Citation>Saw J, Aymong E, Sedlak T, Buller CE, Starovoytov A, Ricci D, et al. Spontaneous coronary artery dissection:association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv. 2014;7:645&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">25294399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamran M, Guptan A, Bogal M. Spontaneous coronary artery dissection:case series and review. J Invasive Cardiol. 2008;20:553&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco C, Starovoytov A, Mancini GB, et al. Spontaneous resolution of LV dysfunction post SCAD:a case series. Paper presented at:SCAI 2015, May 69, 2015; San Diego, CA:</Citation></Reference><Reference><Citation>Saw J. Coronary angiogram classification of spontaneous coronary artery dissection. Catheter Cardiovasc Interv. 2014;84:1115&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">24227590</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretty HC. Dissecting aneurysm of coronary artery in a woman aged 42:rupture. BMJ. 1931;1:667.</Citation></Reference><Reference><Citation>Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, et al. Clinical features, management, and prognosis of SCAD. Circulation. 2012;126:579&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">22800851</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Rodr&#xed;guez N, Fern&#xe1;ndez-Quero M, Villa Gil-Ortega M, Urbano del Moral JA, Ballesteros Prada S, D&#xed;az de la Llera L, et al. Disecci&#xf3;n coronaria espont&#xe1;nea y sus implicaciones pron&#xf3;sticas a largo plazo en una cohorte de 19 casos. Rev Esp Cardiol. 2010;63:1088&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">20804705</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamloo BK, Chintala R, Freedman AN, Potosky A, Malin J, Weiss Smith S. Spontaneous coronary artery dissection:aggressive vs conservative therapy. J Invasive Cardiol. 2010;22:222&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20440039</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMaio SJ, Jr, Kinsella SH, Silverman ME. Clinical course and long-term prognosis of spontaneous coronary artery dissection. Am J Cardiol. 1989;64:471&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2773790</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Lario B, &#xc1;lvarez-Roy L, Mayordomo-G&#xf3;mez S, Garc&#xed;a-Garc&#xed;a JM. Spontaneous coronary artery dissection in systemic lupus erythematosus:case-based review. Rheumatol Int. 2019;39:1821&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31227856</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz S. Spontaneous coronary artery dissection. E-Journal of Cardiology Practice. 2017;14(38) Disponible en: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-14/spontaneous-coronary-artery-dissection .</Citation></Reference><Reference><Citation>Tweet MS, Eleid MF, Best PJ, Lennon RJ, Lerman A, Rihal CS, et al. Spontaneous coronary artery dissection:revascularization versus conservative therapy. Circ Cardiovasc Interv. 2014;7:777&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">25406203</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfonso F, Paulo M, Gonzalo N, Dutary J, Jim&#xe9;nez-Quevedo P, Lennie V, et al. Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol. 2012;59:1073&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22421300</ArticleId></ArticleIdList></Reference><Reference><Citation>Saw J. Spontaneous coronary artery dissection. Can J Cardiol. 2013;29:1027&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">23498840</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfonso F, Bastante T, Rivero F, Cuesta J, Benedicto A, Saw J, et al. Spontaneous coronary artery dissection. Circ J. 2014;78:2099&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">25131524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lempereur M, Fung A, Saw J. Stent malapposition with resorption of intramural hematoma with spontaneous coronary artery dissection. Cardiovasc Diagn Ther. 2015;5:323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4536472</ArticleId><ArticleId IdType="pubmed">26331116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33008148</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>[Circulatory support with venoarterial ECMO in a patient with biventricular Takotsubo cardiomyopathy].</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>104</EndPage><MedlinePgn>100-104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.20000038</ELocationID><Abstract><AbstractText>La cardiomiopat&#xed;a de Takotsubo es una entidad caracterizada por disfunci&#xf3;n ventricular aguda y transitoria, la cual est&#xe1; generalmente relacionada a un evento desencadenante (estr&#xe9;s emocional o f&#xed;sico) y que, por lo general, se presenta con disfunci&#xf3;n sist&#xf3;lica regional del ventr&#xed;culo izquierdo, aunque hasta en un 30% puede ser biventricular. Seg&#xfa;n su severidad, en algunos casos puede condicionar choque cardiog&#xe9;nico refractario a manejo con inotr&#xf3;picos y vasopresores, por lo que para estos casos deben considerarse los dispositivos de asistencia circulatoria. Presentamos el caso de una paciente joven a quien se realiz&#xf3; cambio valvular pulmonar con pr&#xf3;tesis biol&#xf3;gica, la cual siete semanas posteriores a la cirug&#xed;a acudi&#xf3; al servicio de urgencias con derrame peric&#xe1;rdico y fisiolog&#xed;a de tamponade secundario a s&#xed;ndrome pospericardiotom&#xed;a. Por tal motivo se le practic&#xf3; ventana peric&#xe1;rdica, sin embargo durante el transquir&#xfa;rgico present&#xf3; cardiomiopat&#xed;a de Takotsubo biventricular que le condicion&#xf3; choque cardiog&#xe9;nico con insuficiencia mitral y tric&#xfa;spidea severas y refractariedad a tratamiento m&#xe9;dico, as&#xed; como a bal&#xf3;n intraa&#xf3;rtico de contrapulsaci&#xf3;n (BIAC), por lo cual requiri&#xf3; soporte circulatorio con ECMO venoarterial durante 5 d&#xed;as.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lazcano-D&#xed;az</LastName><ForeName>Emmanuel A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Servicio de Terapia Intensiva Cardiovascular, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez de M&#xe9;xico, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Ruiz</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Departamento de Cuidados Intensivos Posquir&#xfa;rgicos Cardiovasculares, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez, Secretar&#xed;a de Salubridad y Asistencia, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarre-&#xc1;lvarez</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez de M&#xe9;xico, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-&#xc1;lvarez</LastName><ForeName>Rolando J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Departamento de Terapia Intensiva Posquir&#xfa;rgica, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucio-Reta</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Terapia Posquir&#xfa;rgica, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez de M&#xe9;xico, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Cruz</LastName><ForeName>Edgar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad de Terapia Intensiva Cardiovascular, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Velazco</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departamento de Cuidados Intensivos Posquir&#xfa;rgicos Cardiovasculares, Secretar&#xed;a de Salud, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Enr&#xed;quez</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Departamento de Terapia Intensiva Posquir&#xfa;rgica, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melano-Carranza</LastName><ForeName>Efr&#xe9;n</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Cuidados Intensivos Posquir&#xfa;rgicos Cardiovasculares, Secretar&#xed;a de Salubridad y Asistencia, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Mart&#xed;nez</LastName><ForeName>Luis E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Departamento de Hipertensi&#xf3;n Pulmonar y Coraz&#xf3;n Derecho, Hospital de Cardiolog&#xed;a, Centro M&#xe9;dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranda-Tovar</LastName><ForeName>Francisco M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Unidad de Terapia Intensiva Cardiovascular, Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Soporte circulatorio con ECMO venoarterial en paciente con cardiomiopat&#xed;a de Takotsubo biventricular.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054549" MajorTopicYN="N">Takotsubo Cardiomyopathy</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>La cardiomiopat&#xed;a de Takotsubo es una entidad caracterizada por disfunci&#xf3;n ventricular aguda y transitoria, la cual est&#xe1; generalmente relacionada a un evento desencadenante (estr&#xe9;s emocional o f&#xed;sico) y que, por lo general, se presenta con disfunci&#xf3;n sist&#xf3;lica regional del ventr&#xed;culo izquierdo, aunque hasta en un 30% puede ser biventricular. Seg&#xfa;n su severidad, en algunos casos puede condicionar choque cardiog&#xe9;nico refractario a manejo con inotr&#xf3;picos y vasopresores, por lo que para estos casos deben considerarse los dispositivos de asistencia circulatoria. Presentamos el caso de una paciente joven a quien se realiz&#xf3; cambio valvular pulmonar con pr&#xf3;tesis biol&#xf3;gica, la cual siete semanas posteriores a la cirug&#xed;a acudi&#xf3; al servicio de urgencias con derrame peric&#xe1;rdico y fisiolog&#xed;a de tamponade secundario a s&#xed;ndrome pospericardiotom&#xed;a. Por tal motivo se le practic&#xf3; ventana peric&#xe1;rdica, sin embargo durante el transquir&#xfa;rgico present&#xf3; cardiomiopat&#xed;a de Takotsubo biventricular que le condicion&#xf3; choque cardiog&#xe9;nico con insuficiencia mitral y tric&#xfa;spidea severas y refractariedad a tratamiento m&#xe9;dico, as&#xed; como a bal&#xf3;n intraa&#xf3;rtico de contrapulsaci&#xf3;n (BIAC), por lo cual requiri&#xf3; soporte circulatorio con ECMO venoarterial durante 5 d&#xed;as.</AbstractText></OtherAbstract><CoiStatement>Los autores declaran no tener conflicto de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33008148</ArticleId><ArticleId IdType="pmc">PMC8258904</ArticleId><ArticleId IdType="doi">10.24875/ACM.20000038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Finkelstein Y, Shemesh J, Mahlab K, Abramov D, Bar-El Y, Sagie A, et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz. 2002;27(8):791&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12574898</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, Cemin R, et al. COPPS Investigators. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS):a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31(22):2749&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">20805112</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, et al. COPPS-2 Investigators. Colchicine for Prevention of postpericardiotomy syndrome and postoperative atrial fibrillation:the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25172965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on Takotsubo syndrome (Part I):Clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991216</ArticleId><ArticleId IdType="pubmed">29850871</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitel I, von Knobelsdorff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA. 2011;306:277&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">21771988</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashed A, Won S, Saad M, Schreiber T. Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to Takotsubo cardiomyopathy. BMJ Case Rep. 2015;2015:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434270</ArticleId><ArticleId IdType="pubmed">25953675</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshioka T, Hashimoto A, Tsuchihashi K, Nagao K, Kyuma M, Ooiwa H, et al. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy) Am Heart J. 2008;155:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18294491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonacchi M, Maiani M, Harmelin G, Sani G. Intractable cardiogenic shock in stress cardiomyopathy with left ventricular outflow tract obstruction:is extra-corporeal life the best treatment? Eur J Heart Fail. 2009;11:721.</Citation><ArticleIdList><ArticleId IdType="pubmed">19468019</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27238778</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1699-5198</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>Nutricion hospitalaria</Title><ISOAbbreviation>Nutr Hosp</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20960/nh.95</ELocationID><Abstract><AbstractText>Introducci&#xf3;n: el reci&#xe9;n nacido prematuro de muy bajo peso (RNMBP) es inmunol&#xf3;gicamente inmaduro y adem&#xe1;s presenta una alteraci&#xf3;n de las barreras naturales de defensa.&#xa0;Objetivo: evaluar los efectos que pueda tener la administraci&#xf3;n de calostro orofar&#xed;ngeo, administrado durante los primeros 15 d&#xed;as posnatales, sobre los niveles de inmunoglobulina A (IgA) s&#xe9;rica en reci&#xe9;n nacidos prematuros de muy bajo peso durante el primer mes de vida. Material y m&#xe9;todos: se desarroll&#xf3; un estudio de intervenci&#xf3;n no aleatorizado con grupo control, en el que se incluyeron 38 reci&#xe9;n nacidos con &#x2264; 32 + 6 semanas de gestaci&#xf3;n y/o menores de 1.500 g de peso. Los sujetos recibieron 0,2 ml de calostro de su madre cada 4 h, inici&#xe1;ndose el procedimiento en las primeras 24 h de vida hasta el 15.o d&#xed;a postnatal. Se midieron los niveles de IgA en la sangre al nacimiento, 3. er , 15.o y 30.o d&#xed;as de vida. Se registraron datos perinatales al nacimiento y durante el periodo de seguimiento.&#xa0;Resultados: IgA s&#xe9;rica aument&#xf3; de forma estad&#xed;sticamente significativa en el grupo de intervenci&#xf3;n (M1 15,84 &#x3bc;g/ml, M2 20,07 &#x3bc;g/ml, M3 23,65 &#x3bc;g/ml, M4 30,34 &#x3bc;g/ml, p 0,001) y en el grupo control (M1 12,48 &#x3bc;g/ml, M2 16,48 &#x3bc;g/ml, p 0,018; M3 19,41 &#x3bc;g/ml, M4 22,48 &#x3bc;g/ml, p 0,001). Al mes de vida, los niveles de IgA s&#xe9;rica fueron significativamente mayores en el grupo de intervenci&#xf3;n que en el grupo control (p 0,026).&#xa0;Conclusiones: este estudio sugiere que la administraci&#xf3;n de calostro orofar&#xed;nge.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;n &#xc1;lvarez</LastName><ForeName>Estefan&#xed;a</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad de Neonatolog&#xed;a. Servicio de Pediatr&#xed;a. Hospital Materno Infantil Virgen de las Nieves. Complejo Hospitalario Universitario de Granada.. estenia.martin.alvarez@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez Cabanillas</LastName><ForeName>Mar&#xed;a Victoria</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a Caballero</LastName><ForeName>Manuela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Serrano L&#xf3;pez</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kajarabille</LastName><ForeName>Naroa</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>D&#xed;az Castro</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ochoa Herrera</LastName><ForeName>Julio Jos&#xe9;</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Maldonado Lozano</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Efectos de la administraci&#xf3;n de calostro orofar&#xed;ngeo en reci&#xe9;n nacidos prematuros sobre los niveles de inmunoglobulina A.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Nutr Hosp</MedlineTA><NlmUniqueID>9100365</NlmUniqueID><ISSNLinking>0212-1611</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003126" MajorTopicYN="Y">Colostrum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="N">Infant, Premature</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019102" MajorTopicYN="N">Infant, Very Low Birth Weight</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008895" MajorTopicYN="N">Milk, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009960" MajorTopicYN="Y">Oropharynx</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Calostro orofar&#xed;ngeo</Keyword><Keyword MajorTopicYN="N">Inmunoglobulina A</Keyword><Keyword MajorTopicYN="N">Inmunolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Leche materna</Keyword><Keyword MajorTopicYN="N">Reci&#xe9;n nacido prematuro</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27238778</ArticleId><ArticleId IdType="doi">10.20960/nh.95</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>